| Literature DB >> 20362226 |
Kazuhiro Tsuji1, Kohichiroh Yasui, Yasuyuki Gen, Mio Endo, Osamu Dohi, Keika Zen, Hironori Mitsuyoshi, Masahito Minami, Yoshito Itoh, Masafumi Taniwaki, Shinji Tanaka, Shigeki Arii, Takeshi Okanoue, Toshikazu Yoshikawa.
Abstract
DNA copy number aberrations in human hepatocellular carcinoma (HCC) cell lines were investigated using a high-density oligonucleotide microarray, and a novel amplification at the chromosomal region 7q21 was detected. Molecular definition of the amplicon indicated that PEG10 (paternally expressed gene 10), a paternally expressed imprinted gene, was amplified together with CDK14 (cyclin-dependent kinase 14; previously PFTAIRE protein kinase 1, PFTK1) and CDK6 (cyclin-dependent kinase 6). An increase in PEG10 copy number was detected in 14 of 34 primary HCC tumors (41%). PEG10, but not CDK14 or CDK6, was significantly overexpressed in 30 of 41 tumors (73%) from HCC patients, compared with their nontumorous counterparts. These results suggest that PEG10 is a probable target, acting as a driving force for amplification of the 7q21 region, and may therefore be involved in the development or progression of HCCs. Copyright 2010 Elsevier Inc. All rights reserved.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20362226 DOI： 10.1016/j.cancergencyto.2010.01.004
Source DB: PubMed Journal: Cancer Genet Cytogenet ISSN： 0165-4608